Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?

By Persiani Roberto  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 1077-1079

Springer Publishing Company

Access to resources Recommend Favorite

Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?

By Alkan Ali  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1430-1430

Humana Press, Inc

Access to resources Recommend Favorite

Ductal carcinoma in situ: how should we treat it?

By Bayraktar Soley   Arun Banu   Glück Stefan  

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 245-256

Future Medicine

Access to resources Recommend Favorite

Are we missing the mTOR target in breast cancer?

By Johnston Stephen  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 607-611

Springer Publishing Company

Access to resources Recommend Favorite

How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide

By McKay Andrew  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 153-159

Springer Publishing Company

Access to resources Recommend Favorite